Friday, September 24, 2010

Focused on Latest Clinical and Diagnostic Advances in Coagulation

BEDFORD, Mass., Sept. 23 /PRNewswire/ -- Instrumentation Laboratory (IL), today announced it will host the 2nd IL Asia Pacific Hemostasis Forum on Wednesday, October 13, 2010 at the Grand Hyatt Nusa Dua, in Bali, Indonesia.  The event will run from 8:00 am to 12:00 pm, local time.  The forum will focus on the latest clinical and diagnostic advances and trends in hemostasis.  All healthcare professionals, practicing in the Asia Pacific region are welcome to attend.  
Professor Karmel Tambunan, MD, PhD, from the Division of Hematology and Medical Oncology at the University of Indonesia, Jakarta will serve as Scientific Chairman of the Forum.  In addition, several prominent experts in the field will present key information and lead discussions during the Forum, including Professor Ismail Elalamy, MD, a Hematologist at the Hopital Tenon, Paris France;  Associate Professor Tatsuya Atsumi, MD, PhD, from the Graduate School of Medicine at Hokkaido University, Sapporo, Japan;  and, Associate Professor Chris Ward, from the Department of Haemotology and Transfusion Medicine at the Royal North Shore Hospital, Sydney, Australia.
Topics will include new approaches and developments in the diagnosis of Heparin-Induced Thrombocytopenia (HIT), as well as new and emerging markers for Antiphospholipid Syndrome (APS) and associated clinical challenges.
"We are so honored to have some of the leading clinicians from around the world sharing their expertise on HIT and APS management and diagnostics," said Santiago Ramos, Regional Manager for North East Asia.  "The Forum will address many of the key issues facing clinicians today and will provide new information to help them deliver the very best patient care."
About HIT
HIT is a severe immune reaction to Heparin that can result in the paradoxical development of a thrombotic event.  One of the most common of all adverse drug effects, due to the sheer volume of patients receiving Heparin therapy (over 12 million patients annually in the US alone), it has a significant impact on anticoagulant management in hospitals worldwide.  If left untreated, patients with HIT may develop serious sequelae, including pulmonary embolism, myocardial infarction, or death.
Registering to Attend
Through October 1st, 2010, individuals can register to attend this Forum, by contacting Carol Lee, at wbj@werfen-china.com

No comments: